Johnson & Johnson (JNJ) Stock Forecast & Price Target
Johnson & Johnson · NYSE
$266.92+0.97 (+0.36%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 19 firms covering Johnson & Johnson, 12 rate it Buy or better, 7 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $208.00 to $300.00, a moderate spread. The average target of $263.65 sits 1% below the current $266.92. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 11 to 12 over recent months. On the fundamentals, the Street sees consensus EPS building from about $3.03 next quarter toward $12.83 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS19 ratings
Moderate Buy
Strong Buy00%
Buy1263%
Hold737%
Sell00%
Strong Sell00%
Based on 19 analysts giving stock ratings to Johnson & Johnson.
As of Jul, 12 of 19 firms rate JNJ a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
JNJ EPS & revenue forecast
EPS · NEXT QUARTER
$3.03
Range $2.93 – $3.20 · 16 analysts · +23% YoY
Next period, 16 analysts expect Johnson & Johnson to earn $3.03 a share (range $2.93 – $3.20), versus $2.46 a year earlier. Full-year consensus is $11.68, growing to $12.83 the year after.
REVENUE · NEXT QUARTER
$26.5B
Range $26.3B – $26.9B · 16 analysts · +8% YoY
Revenue is expected to reach $26.5B (range $26.3B – $26.9B), +7.9% year-over-year. Full-year consensus is $101.3B, rising to $108.4B next year.
Top analysts covering Johnson & Johnson
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on JNJ.
#1
Jason Gerberry
B of A Securities · Rank #136
Hold
$263.00-1.5% to target
Overall win rate
46%
+ Follow
#2
Terence Flynn
Morgan Stanley
Buy
$294.00+10.1% to target
Coverage
—
+ Follow
#3
Joanne Wuensch
Citigroup
Buy
$298.00+11.6% to target
Coverage
—
+ Follow
#4
LB
Larry Biegelsen
Wells Fargo
Buy
$272.00+1.9% to target
Coverage
—
+ Follow
#5
Vamil Divan
Guggenheim
Buy
$270.00+1.2% to target
Coverage
—
+ Follow
JNJ stock forecast FAQ
What is JNJ's average 12-month price target?+
The 17 analysts with a live target average $263.65 for Johnson & Johnson over the next 12 months, ranging from a $300.00 high to a $208.00 low.
Is JNJ stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 19 analyst ratings, 12 are Buy or Strong Buy, 7 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for JNJ?+
The Street-high target is $300.00 (TD Cowen), and the Street-low is $208.00 (Bernstein). The average of all 17 active targets is $263.65.
How many Wall Street analysts cover JNJ?+
19 analysts have an active rating on Johnson & Johnson, and 17 firms carry a live 12-month price target.
Who is the most accurate analyst covering JNJ?+
Among analysts who currently cover JNJ, Jason Gerberry of B of A Securities has the strongest overall Quantellect track record (Rank #136). Their current call is Hold with a $263.00 target.
What is Johnson & Johnson's projected EPS for next quarter?+
The consensus estimate is $3.03 per share (range $2.93 – $3.20) across 16 analysts. Full-year EPS is projected at $11.68, rising to $12.83 the following year.
How much revenue is Johnson & Johnson expected to report next quarter?+
Consensus revenue is $26.5B (range $26.3B – $26.9B). Full-year revenue is projected at $101.3B, growing to $108.4B next year.
Have analysts been upgrading or downgrading JNJ lately?+
As of Jul, 12 of 19 firms rate JNJ a Buy (7 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their JNJ calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
